A review of 331 rhabdomyosarcoma cases in patients treated between 1991 and 2002 in Japan

[1]  K. Nakada.  The clinical features and prognosis of rhabdomyosarcoma: Follow-up studies on pediatric tumors from the Japanese pediatric tumor registry 1971–1980. Part II , 1990, The Japanese Journal of Surgery.

[2]  H. Kawamoto,et al.  Possible Benefits of High-Dose Chemotherapy as Intensive Consolidation in Patients with High-Risk Rhabdomyosarcoma Who Achieve Complete Remission with Conventional Chemotherapy , 2003, Pediatric hematology and oncology.

[3]  P. Sorensen,et al.  PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  James R. Anderson,et al.  Prognostic factors and outcome in children with metastatic rhabdomyosarcoma - a report from the intergroup rhabdomyosarcoma study IV , 2001 .

[5]  James R. Anderson,et al.  Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  James R. Anderson,et al.  Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V , 2001, Journal of pediatric hematology/oncology.

[7]  M. Fukuzawa,et al.  Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors , 1998, Bone Marrow Transplantation.

[8]  James R. Anderson,et al.  Pretreatment TNM staging of childhood rhabdomyosarcoma , 1997, Cancer.

[9]  E. Gehan,et al.  The Third Intergroup Rhabdomyosarcoma Study. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  T. Sawada,et al.  Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group. , 1994, Progress in clinical and biological research.

[11]  E. Gehan,et al.  Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS-II). , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.